Glucagon is a pancreatic hormone that plays a crucial role in regulating glucose and whole-body energy metabolism. In individuals with diabetes, the pancreatic alpha cells that produce glucagon are ...

With the rise of glucagon-like-peptide-1 receptor agonist medications (GLP-1RA) for obesity treatment, understanding diet quality can be a valuable tool for providing evidence-based nutrition guidance ...

Those with Type 1 diabetes (T1D) have higher glucagon levels right after eating than healthy individuals, but the reason why had not been determined. Using a novel glucagon isotope tracer, UAB ...

Our findings suggest that GLP-1 therapy holds real promise. While a randomized trial is still needed, the fact that many patients with IIH already qualify for GLP-1s due to diabetes or obesity means ...

In early 2025, around 4.9 million British adults — almost one in ten — are estimated to have recently used, or expressed interest in using, glucagon-like peptide-1 (GLP-1) or dual ...

Indianapolis-based pharma giant Eli Lilly has announced the company now offers an Android version of its app, called Glucagon, which is designed to help caregivers and providers treat people with ...

STOCKHOLM — A closed-loop insulin-delivery system, dubbed the 'artificial beta cell,' improved glucose control and reduced hypoglycemia compared with sensor-augmented insulin-pump therapy in patients ...

When a person with Type 1 diabetes develops severe hypoglycemia (more commonly known as low blood sugar), they turn to glucagon. This hormone, produced in limited quantities by the pancreas, orders ...

Xeris Biopharma Holdings has received regulatory approval for a new use of its Gvoke liquid glucagon in gastrointestinal radiologic exams, expanding the product's sales base beyond diabetic patients ...

(HealthDay News) — For patients with type 2 diabetes, once-daily treatment with the glucagon receptor antagonist LY2409021 is associated with increases in ambulatory blood pressure (BP), according to ...

CHICAGO--(BUSINESS WIRE)-- Xeris Biopharma Holdings, Inc. (XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products ...